PACS Group, Inc. (PACS) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $158.00K; Additional Paid in CapitalUSD $643.60M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $466.64M.
- 2026-03-31: Common Stock, Value, IssuedUSD $157.00K; Additional Paid in CapitalUSD $646.74M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $390.27M.
- 2025-12-31: Common Stock, Value, IssuedUSD $157.00K; Additional Paid in CapitalUSD $637.03M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $309.58M.
- 2025-09-30: Common Stock, Value, IssuedUSD $157.00K; Additional Paid in CapitalUSD $621.29M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $249.88M.
PACS Group, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $158.00K | $643.60M | (m) | $466.64M | $1.11B | $1.12B | (m) | 3 month · $25.83M | (m) |
| 2026-03-31 | $157.00K | $646.74M | (m) | $390.27M | $1.04B | $1.04B | (m) | 3 month · $20.35M | (m) |
| 2025-12-31 | $157.00K | $637.03M | (m) | $309.58M | $946.77M | $952.45M | (m) | (m) | (m) |
| 2025-09-30 | $157.00K | $621.29M | (m) | $249.88M | $871.32M | $876.92M | 3 month · $12.52M | (m) | (m) |
| 2025-06-30 | $157.00K | $609.21M | (m) | $197.47M | $806.84M | $812.67M | 3 month · $13.60M | 3 month · $13.60M | (m) |
| 2025-03-31 | $155.00K | $603.57M | (m) | $146.51M | $750.23M | $756.27M | 3 month · $12.20M | 3 month · $12.20M | (m) |
| 2024-12-31 | $155.00K | $591.36M | (m) | $118.04M | $709.55M | $715.69M | (m) | (m) | 12 month · $953.00K |
| 2024-09-30 | $155.00K | $579.06M | (m) | $80.83M | $660.05M | $666.74M | (m) | 3 month · $12.30M | (m) |
| 2024-06-30 | $152.00K | $471.47M | (m) | $65.22M | $536.84M | $542.95M | (m) | 3 month · $90.94M | 3 month · $502.00K |
| 2024-03-31 | $129.00K | (m) | $201.00K | $113.34M | $113.67M | $119.27M | (m) | (m) | (m) |
| 2023-12-31 | $129.00K | $0.00 | $0.00 | $96.00M | $96.13M | $101.73M | (m) | (m) | 12 month · $587.00K |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | $78.99M | (m) | (m) | 3 month · $587.00K |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | $83.74M | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | $87.74M | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $68.65M | (m) | (m) | 12 month · $3.25M |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | $-24.81M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATIONAL HEALTHCARE CORP (NHC) | United States | $3.473B | 23.65 |
| ENSIGN GROUP, INC (ENSG) | United States | $10.098B | 24.68 |